Tags

Type your tag names separated by a space and hit enter

Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Exp Nephrol. 1995 Sep-Oct; 3(5):270-9.EN

Abstract

The role of xanthine oxidase as a source of reactive oxygen species in puromycin aminonucleoside nephrosis was examined. The effects of allopurinol (a xanthine oxidase inhibitor as well as a reactive oxygen species scavenging enzyme) and tungsten (a specific xanthine oxidase inhibitor) on glomerular epithelial cell ultrastructure, renal xanthine oxidase and xanthine dehydrogenase activity, and urinary protein excretion were examined in puromycin aminonucleoside-treated rats. Co-administration of allopurinol to such rats reduced proteinuria by approximately 70% over the 10 days studied, and reduced the degree of glomerular epithelial cell foot process effacement at both 5 and 10 days, compared to rats that received puromycin aminonucleoside alone. Unexpectedly, co-administration of allopurinol to puromycin aminonucleoside-treated rats did not reduce xanthine oxidase activity; however, the combined activity of xanthine oxidase and xanthine dehydrogenase in such animals was reduced on day 5. Co-administration of tungsten to puromycin aminonucleoside-treated rats did not reduce proteinuria or alter the number of filtration slits. Rats co-administered tungsten and puromycin aminonucleoside had significantly reduced renal xanthine oxidase and combined xanthine oxidase and xanthine dehydrogenase activities on days 5 and 10, compared to rats treated with puromycin aminonucleoside alone. These results provide evidence that the protection provided by allopurinol in puromycin aminonucleoside-treated rats is due to the antioxidant properties of allopurinol, rather than to its activities as a xanthine oxidase inhibitor.

Authors+Show Affiliations

Department of Anatomy and Cell Biology, University of Melbourne, Parkville, Vic., Australia.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7583048

Citation

Ricardo, S D., et al. "Podocyte Architecture in Puromycin Aminonucleoside-treated Rats Administered Tungsten or Allopurinol." Experimental Nephrology, vol. 3, no. 5, 1995, pp. 270-9.
Ricardo SD, Bertram JF, Ryan GB. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol. 1995;3(5):270-9.
Ricardo, S. D., Bertram, J. F., & Ryan, G. B. (1995). Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Experimental Nephrology, 3(5), 270-9.
Ricardo SD, Bertram JF, Ryan GB. Podocyte Architecture in Puromycin Aminonucleoside-treated Rats Administered Tungsten or Allopurinol. Exp Nephrol. 1995 Sep-Oct;3(5):270-9. PubMed PMID: 7583048.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. AU - Ricardo,S D, AU - Bertram,J F, AU - Ryan,G B, PY - 1995/9/1/pubmed PY - 1995/9/1/medline PY - 1995/9/1/entrez SP - 270 EP - 9 JF - Experimental nephrology JO - Exp Nephrol VL - 3 IS - 5 N2 - The role of xanthine oxidase as a source of reactive oxygen species in puromycin aminonucleoside nephrosis was examined. The effects of allopurinol (a xanthine oxidase inhibitor as well as a reactive oxygen species scavenging enzyme) and tungsten (a specific xanthine oxidase inhibitor) on glomerular epithelial cell ultrastructure, renal xanthine oxidase and xanthine dehydrogenase activity, and urinary protein excretion were examined in puromycin aminonucleoside-treated rats. Co-administration of allopurinol to such rats reduced proteinuria by approximately 70% over the 10 days studied, and reduced the degree of glomerular epithelial cell foot process effacement at both 5 and 10 days, compared to rats that received puromycin aminonucleoside alone. Unexpectedly, co-administration of allopurinol to puromycin aminonucleoside-treated rats did not reduce xanthine oxidase activity; however, the combined activity of xanthine oxidase and xanthine dehydrogenase in such animals was reduced on day 5. Co-administration of tungsten to puromycin aminonucleoside-treated rats did not reduce proteinuria or alter the number of filtration slits. Rats co-administered tungsten and puromycin aminonucleoside had significantly reduced renal xanthine oxidase and combined xanthine oxidase and xanthine dehydrogenase activities on days 5 and 10, compared to rats treated with puromycin aminonucleoside alone. These results provide evidence that the protection provided by allopurinol in puromycin aminonucleoside-treated rats is due to the antioxidant properties of allopurinol, rather than to its activities as a xanthine oxidase inhibitor. SN - 1018-7782 UR - https://www.unboundmedicine.com/medline/citation/7583048/Podocyte_architecture_in_puromycin_aminonucleoside_treated_rats_administered_tungsten_or_allopurinol_ DB - PRIME DP - Unbound Medicine ER -